Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study

ReutersMar 26, 2025 11:43 AM

March 26 (Reuters) - Leap Therapeutics Inc LPTX.O:

LEAP THERAPEUTICS REPORTS POSITIVE UPDATED DATA FROM SIREXATAMAB COLORECTAL CANCER STUDY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Ethereum Surges Over 8% in a Day Outperforming BTC, Has the Altcoin Market Been Activated?

Ethereum’s surge outpaces Bitcoin as market risk appetite rebounds significantly, suggesting that higher-volatility altcoins may become increasingly favored.

ASML 2026 Q1 Earnings Preview: Valuations Are Already at Highs, Can AI Orders Support Growth Expectations?

TradingKey - Global lithography leader ASML is set to disclose its first-quarter 2026 financial results on April 15. Market focus on the company's short-term performance volatility and long-term growth potential continues to intensify.

Microsoft Surface Price Hikes Trigger Memory Shortage: Which Storage Chip Giant Among SK Hynix, Micron, and SanDisk Is More Worth Investing In?

TradingKey - Microsoft raises Surface prices, sparking market concerns over a memory shortage and signaling continued investment opportunities in memory stocks.

Brent Spot $190 Warning: WTI Flips Global Benchmark in Rare Price Inversion as Geopolitical Tensions Flare

TradingKey - Since April, as the conflict in the Middle East has continued to escalate, the oil market has undergone a dramatic transformation: WTI crude has been repriced, not only matching the performance of the global benchmark Brent crude but also surpassing it during several trading sessions. O

Musk’s XChat Is Coming to App Store, Meta, Apple and Finance World Are Trembling

Elon Musk’s XChat, the Western equivalent of WeChat, is set to launch on the App Store, issuing a direct challenge to giants such as Meta, Apple, and PayPal.

Featured Tools